Atea Pharmaceuticals Inc (AVIR)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -127.16 | -2.472 | 14.811 | -16.198 | -21.552 |
| Return on Equity (%) | 56.622 | -4.394 | 19.269 | -17.265 | -22.74 |
| Return on Invested Capital (%) | -150.435 | -3.89 | 19.244 | -18.878 | -27.755 |
| Operating Margin (%) | N/A | -22.509 | 39.443 | N/A | N/A |
| Net Profit Margin (%) | N/A | -22.509 | 34.491 | N/A | N/A |
| Book Value Per Share | 1.937 | 10.322 | 8.545 | 7.691 | 6.654 |
| Earnings Per Share | -1.391 | -0.206 | 1.458 | -1.4 | -1.629 |
| Cash Per Share | 2.147 | 16.019 | 9.198 | 2.263 | 1.724 |
| Working Capital Per Share | 1.93 | 10.32 | 8.61 | 7.714 | 6.689 |
| Operating Profit Per Share | N/A | 0.916 | 4.228 | N/A | N/A |
| EBIT Per Share | -1.391 | -0.206 | 1.668 | -1.435 | -1.617 |
| EBITDA Per Share | -1.391 | -0.206 | 1.668 | -1.435 | -1.617 |
| Free Cash Flow Per Share | -1.392 | -0.206 | 1.458 | -1.38 | -1.634 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | 8.998 | 2.734 | 13.579 | 35.768 | 18.237 |
| Quick Ratio | 8.896 | 2.692 | 13.438 | 34.999 | 17.856 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 10.09M | 53.07M | 83.1M | 83.29M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | N/A | 83.29M | 83.29M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 51.16 | N/A | N/A | N/A | 13.284 |
| Quick Ratio | N/A | N/A | N/A | 50.197 | N/A | N/A | N/A | 13.108 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 321.73M |
| Price to Earnings Ratio | -2.37 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.24 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 84.22M |
| Average Volume (1 week) | 179.52k |
| Average Volume (1 Month) | 205.42k |
| 52 Week Change | 12.68% |
| 52 Week High | 4.60 |
| 52 Week Low | 2.765 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
